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ABSTRACT 
 
Keywords: PDZ domains, allostery, molecular dynamics simulations, free energy 
calculations 
 
 
PDZ domain-containing proteins are involved in intercellular interactions such as 
trafficking, signaling, cell to cell communication and organization of signaling 
complexes. PDZ domains are themselves small proteins which typically consist of 90 to 
100 amino acids. However, the extra α helix structure at the carboxyl terminus introduces 
a selective structural feature to the third PDZ domain of PSD-95 which has a stabilizing 
effect and participates in allosteric communication. PDZ domains are the most commonly 
studied models to understand single domain allostery without resulting in significant 
structural changes. One change triggers another change at distal site, and the source of 
the ‘changes’ are localized perturbations such as a binding event, posttranslational 
modification, a mutation or light absorption. Mutations can alter the stabilization of the 
protein and result ON or OFF state for ligand binding. They can also cause a change in 
the active site and affect the ligand preference. Here we investigate the reasons leading to 
the allosteric regulation of mutations and their effect on the ligand preferences. 
By using third PDZ domain of postsynaptic density 95 (PSD-95) as a model 
system H372 directly connected to the binding site and G330 with a somewhat removed 
position were selected to assess the effect of allosteric mutations on the dynamics. In the 
literature, it was observed that the H372A and G330T/H372A mutations change ligand 
preferences from class I (T/S amino acid preference at position 2 of the ligand) to class II 
(hydrophobic amino acid preference at position 2 of the ligand). On the other hand, the 
G330T mutation leads to the recognition of both class I and class II types of ligands. 
Therefore, H372A is a ‘switching mutation’ while G330T mutation is ‘class bridging’. 
We have performed 200 ns molecular dynamics simulations for wild-type, H372A, 
G330T single mutants and a double mutant of third PDZ domain in the absence and 
presence of both types of ligands. The comparative study helps to identify the changes in 
the dynamics that are effective in the onset and prevention of allosteric communication. 
With the combination of free energy difference calculations and a detailed analysis of 
MD trajectories, the behavior of the PDZ domain under the mutations, which are ‘class 
bridging’(G330T) and ‘class changing’(H372A), and their effects on the ligand 
preferences and binding affinities are explained. We show that the ensemble view of 
allostery provides a better description of site-to-site coupling rather than a pathway view 
that assumes a direct connection between the effector and binding sites. 
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ÖZET 
 
Anahtar kelimeler: PDZ bölgeleri, allosteri, moleküler dinamik simülasyonları, serbest 
enerji hesaplamaları 
 
 PDZ bölgeleri içeren proteinler sinyalleşme, hücre-hücre iletişimi, sinyalleşme 
komplekslerinin organizasyonu gibi hücreler arası etkileşimlerde yer alırlar. PDZ 
bölgeleri 90 ila 100 aminoasit içeren küçük proteinlerdir. Bununla birlikte, karboksil 
terminalindeki ekstra alfa sarmal yapısı, PSD-95'in üçüncü PDZ bölgesine stabilize edici 
ve allosterik iletişime katılan seçici bir yapısal özellik kazandırır. PDZ bölgeleri, önemli 
yapısal değişikliklere yol açmayan allosteriyi anlamak için en çok çalışılan modeller 
moleküllerdir. Bir değişiklik, uzak bir bölgede başka bir değişikliği tetikler ve bu 
"değişikliklerin" kaynağı, bir molekül bağlama olayı, genetik çeviri sonrası 
modifikasyon, mutasyon veya ışık soğurumu gibi bölgesel sarsımlardır. Mutasyonlar 
proteinin stabilizasyonunu değiştirebilir ve proteini ligand bağlanması için açık veya 
kapalı duruma getirebilir. Ayrıca aktif bölgede değişikliğe sebep olarak ligand tercihini 
etkileyebilirler. Bu çalışmada, mutasyonların allosterik regülasyonlara yol açan sebepleri 
ve ligand tercihleri üzerindeki etkileri araştırılmıştır. 
 Postsinaptik yoğunluk 95 (PSD-95) proteininin üçüncü PDZ bölgesi model 
sistem olarak kullanılarak; doğrudan bağlanma bölgesiyle ilişkili H372 ve bağlanma 
bölgesinden biraz uzaktaki G330 amino asitleri, allosterik mutasyonların protein dinamiği 
üzerindeki etkisini anlamak için seçilmiştir. Literatürde H372A ve G330T / H372A 
mutasyonlarının ligand tercihlerini sınıf I'den (ligandın 2. pozisyonunda T / S kalıntı 
tercihi) sınıf II'ye (ligandın 2. pozisyonunda hidrofobik amino asit tercihi) değiştirdiği 
gözlenmiştir. Öte yandan G330T mutasyonu hem sınıf I hem de sınıf II tip ligandların 
kabul edilmesine yol açar. Bu sebeple, H372A ‘sınıf değiştirme mutasyonu’, G330T 
mutasyonu ‘sınıf köprüleyen mutasyon’ olarak adlandırılır. Üçüncü PDZ bölgesinin 
yabanıl tip, H372A ve G330T tek mutasyonlu ve her iki mutasyonu da barındıran 
durumları için, her iki tip ligandın varlığında ve yokluğunda 200 ns’lık moleküler 
dinamik simülasyonlarını ikişer defa gerçekleştirdik. Karşılaştırmalı çalışma, allosterik 
iletişimin tetiklenmesinde ve engellenmesinde etkili olan dinamiklerdeki değişimlerin 
belirlenmesine yardımcı olmaktadır. Serbest enerji değişimleri hesaplamaları ve 
simülasyon süreçlerinin detaylı analizleri ile, ‘sınıf birleştiren’ (G330T) ve ‘sınıf 
değiştiren’ (H372A) mutasyonların; PDZ bölgelerinin davranışı, ligand tercihleri ve 
bağlanma afiniteleri üzerindeki etkileri açıklanmıştır. Çalışmamız, bu proteinde 
gözlemlenen allosterinin “genel uyum” görüşünün, bölgeden bölgeye bağlantıyı 
tanımlamak için, efektör ve bağlanma alanları arasında doğrudan bir bağlantı olduğunu 
kabul eden “yolak anlayışı”na göre daha iyi bir tanım olduğunu göstermektedir. 
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Chapter 1 
 
Introduction and Motivation 
 
1.1 PDZ Domain Family 
PDZ domain-containing proteins were first recognized in the early 1990s.  Such 
proteins involve intercellular interactions such as trafficking, signaling, cell to cell 
communication and organization of signaling complexes [1, 2]. They are found in a wide 
variety of organisms from bacteria to vertebrates.  For instance, the human proteome has 
over 250 different variations of PDZ domain-containing proteins [1]. The domain’s 
abbreviation stems from the very first discovered PDZ-containing proteins –  PSD95 
(postsynaptic density protein 95) P, the Drosophila tumor suppressor protein Dlg-1 (discs 
large) D, and ZO-1 (zonula occludens protein) Z [3] (Fig 1.1). PSD-95 and Dlg-1 are 
homologous – mostly similar with respect to their sequences – insofar as they both have 
three PDZ domains with Src Homology 3 (SH3) and guanylate kinase (GK) domains at 
their C-termini [4]. SH3 domains are specific motifs, target proteins which have a role in 
signaling pathways [5]. GK domain is one of the members of Membrane-associated 
guanlylate kinases (MAGUKs) which are responsible for cell to cell interaction and cell 
polarity control [6]. However, in spite of extensive knowledge on MAGUK family, the 
information in the GK domain is very limited [6]. Unlike SH3 and GK domains, ZU5 
domain is found only in Zonula Occludens Protein (ZO-1), and it contributes to the 
stabilization of ZO-1 protein [7]. 
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Figure 1.1. Schematic representation of PDS-95, DLG-1, and ZO-1. 
 
PDZ domain-containing proteins consist of varying numbers of PDZ domains, 
demonstrating a great variety among species which account for the abundance of the PDZ 
domains [8]. However, it is yet to be determined if the number of domains has a 
significant effect on the function of PDZ domain-containing proteins. 
PDZ domains are themselves small proteins which typically consist of 90 to 100 
amino acids and have 6-7 β-strands and 2 α-helical structures as characteristic features 
[1-5]. Common structural motifs are consistent in the folding respect but differ in length 
amongst the PDZ domain family [9] (Fig. 1.3). In addition to its secondary structure, the 
loop at the binding cleft, referred to as the carboxylate-binding loop, is one of the 
hallmarks of the PDZ domain [10]. This loop consists of ‘GLGF’ amino acids, and, 
therefore, PDZ domains are also known as ‘GLGF repeats’ [8, 11]. However, there is a 
selective structural feature of the third PDZ domain of PSD-95 which makes it more 
interesting to work on; it is the extra α helix structure at the carboxyl terminus [12] (Fig 
1.2). Studies reveal the significance of the unusual α-helix, which has a stabilizing effect 
and participates in allosteric communication [12, 13]. 
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Figure 1.2. The third PDZ domain of PSD-95. 
 
Members of the PDZ domain family bind selectively to short amino acid patterns at 
the C-termini of binding proteins [14]. Therefore, the pattern of the target protein is the 
definitive factor for the classification of PDZ domains [1]. PDZ domain-binding protein 
interactions are categorized based on the amino acid at the second position of the binding 
protein downstream from the C-Terminus [10, 15]. - Class-I for Thr/Ser, Class-II for 
hydrophobic amino acids, and Class-III for Asp/Glu [10, 16, 17].  
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Figure 1.3. Schematic of the Secondary structure of third PDZ domain. Secondary 
structure, purple represents α helix, yellow shows β strands (A). Schematic representation 
of the secondary structure (B).  
 
For this study, the third PDZ domain of PSD-95 is used as a model protein. For 
this protein, Class I and Class II interactions are possible (Fig 1.4A). There are two 
determinant residues affecting ligand preference – His372 and Gly330 [18]. His372 is at 
the binding pocket of the protein and has direct contact with the ligand. On the other hand, 
Gly330 does not have direct contact with ligands, but it is located on the right loop of the 
binding pocket [18]. It has been proven that mutations on these two residues alter the 
protein’s affinity to different classes of ligands [18]. The wild-type (WT) third PDZ 
domain prefers to bind ligands of Class I (Fig. 1.4B). On the contrary, if His372 is 
mutated into Alanine, the binding protein can bind to Class II instead of Class I. Due to 
the resulting change in ligand preference, H372A mutations are called class changing 
mutations [18] (Fig. 1.4B). While the H372A mutation has the inhibitory effect on Class 
I, a Gly to Thr mutation at the 330th residue allows the binding protein to bind both 
Classes I and II ligands. Mutations such as G330T mutations are called class bridging 
mutations [18] (Fig. 1.4B). If the binding protein undergoes both H372A and G330T 
5 
 
mutations simultaneously as a double mutant (DM), the protein binds Class-II ligands 
only; i.e. the double mutation is also class changing [18] (Fig. 1.4B). 
 
Figure 1.4. Binding site and ligand preferences. Schematic of the binding pocket and 
ligand classes (A). The change of ligand preferences due to mutation types accordingly 
(B). 
1.2 PDZ Domains as Models of Allostery 
 Allostery is originated from Greek word, meaning "other sites", where 
perturbations at one site of the protein, can influence changes at a distal site, complicating 
deducing structure-function relationship in proteins, the concept has changed in the years 
[19, 20]. In 1904 the 'Bohr effect' concept which was describing the effect of CO2 on the 
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binding affinity of O2 to hemoglobin was proposed [21]. With the description of this new 
concept, the era leading to the naming of ‘allostery’ begun [21].  
 
 The word ‘allostery’ first appeared in 1961, and in 1963 the concept of 
‘allosteric sites’ was used instead of ‘regulatory sites’ by Jacques Monod [22]. In the 
1960s two significant concepts were described: the first one is the concerted model of 
Monod, Wyman, and Changeux (MWC) model and the second one is the sequential 
model which was proposed by Koshland, Némethy, and Filmer (KNF) [23]. Both models 
take cooperativity as the key regulatory. The conformational changes were taken as a 
signature of allostery until 1984 [21, 24]. In 1984, the ‘dynamic allostery’ concept was 
described by Cooper and Dryden which describes allostery without the need of 
conformational change by introducing the entropy contribution [21, 25]. With the 
introduction of non-conformational change allostery, in addition to multi-domain 
proteins, single domain ones started to be investigated for a better understanding of 
allostery. PDZ domains are the most commonly studied models to understand single 
domain allostery without resulting in significant structural changes [26]. 
  
 The required localized perturbation for allosteric regulation can cause by a 
binding event, post-transitional modifications or mutations [27]. Mutations attributes in 
two significant regulations. Firstly, it can alter the stabilization of the protein and result 
ON or OFF state for ligand binding [28]. Secondly, it can cause a change in the active 
site and affect the ligand preference [28]. In this study, the reason for the allosteric 
regulation is mutation and its effect on the ligand preferences.  
1.3 The Scope of the Thesis  
PDZ domains themselves are small proteins, typically composed of 90 to 100 
amino acids [1-5]. The extra α-helix structure at the carboxyl terminal is the specific 
structural property of the third PDZ domain of PSD-95, which is why it is widely studied 
[12]. To work on the third PDZ field of PSD-95 is appealing not only because of the 
additional α-helical structure but also due to its significance and abundance in the 
understanding of single domain allostery. In 1999, with the introduction of the allosteric 
networks of PDZ [29], PDZ domains became the preferred model to understand the single 
domain allostery 
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We performed 200 ns molecular dynamics simulations for wild-type, H372A, 
G330T single mutants and a double mutant of third PDZ domain in the absence and 
presence of both types of ligands described in figure 1.4. The comparative study helps to 
identify the changes in the dynamics that are effective in the onset and prevention of 
allosteric communication.  
 The first step in this work has been to use 50 ns apart snapshots from the MD 
trajectories to carry out free energy perturbation calculations. As a result, it is possible to 
make a thermodynamic assessment of ligand binding which is the key to understanding 
the function. With the combination of Free Energy Perturbation (FEP) results and a 
detailed analysis of MD trajectories, the behavior of the PDZ domain under the mutations, 
which are ‘class bridging’(G330T) and ‘class changing’(H372A), and their effects on the 
ligand preferences and binding affinities are explained. We conclude with a simple model 
for explaining PDZ domain allostery by considering entropy-enthalpy compensation. 
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Chapter 2 
 
Theory and Method 
 
2.1 Molecular Dynamics (MD) Simulations 
MD simulations were carried out with Nanoscale Molecular Dynamics (NAMD) 
program using CHARMM36 force field parameters.  The simulations were visualized 
using the molecular graphics program VMD [30]. 
The very first concept and keywords of the MD simulations to understand protein 
folding were introduced in 1975 [31]. MD is a Newtonian physics-based approach used 
for the understanding of molecular conformations, interactions and rearrangements 
[32][33].  
The first step in an MD simulation of a protein is to obtain its structural 
information (coordinates) from the Protein Data Bank (PDB). The protein is placed into 
a water box whereby a distance (10 Å) is maintained between each atom of the protein 
and the nearest edge of the water box by using the solvent plug-in in VMD 1.9.3. By 
adding a sufficient number of potassium chloride (KCl) to the system, the ionic strength 
is adjusted to 150 mM after achieving charge neutrality. Long-range electrostatics are 
calculated by the particle mesh Ewald method [34], with a cut-off distance of 12 Å. 
Temperature control is maintained by Langevin Dynamics. The system is run under 1 atm 
and 310 K in the NPT ensemble. The complete system is minimized for 10,000 steps and 
equilibrated for 100,000,000 steps. Each step is 2 fs.  
This procedure is repeated twice for 12 proteins. Their PDB codes are presented 
in Table2.1.  
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Table 2.1. PDB codes of model proteins. 
 
 
2.1.1 Trajectory Analysis 
Trajectory analysis was carried out considering two sets of simulations. For 
RMSF, cross-correlation, and hydrogen-bond occupancy analyses, the first 80 ns of the 
MD simulation (200 ns) were excluded for the molecule to get equilibrated. The 
remaining 120 ns was divided into three equal 40 ns chunks. Their average is used for 
RMSF and cross-correlation calculations. 
2.1.1.1 Root Mean Square Deviation (RMSD) 
For understanding the similarities and differences between two three-dimensional 
structures, calculating the root mean square deviation (RMSD) is one of the most widely 
used methods [1]. RMSD defined as:  
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𝑅𝑀𝑆𝐷 (𝑡ଶ, 𝑡ଵ) = ඨ
ଵ
ேഀ
෍ ൫ൻ𝑅ሬ⃗ ఈ𝑡ଶൿ − ൻ𝑅ሬ⃗ ఈ𝑡ଵൿ൯
ଶேഀ
ఈୀଵ
   (1) 
where 𝑁ఈ is the total number of 𝐶ఈ atoms in the molecule, 𝑅ሬ⃗ ఈ is the atomic position of 
the α atom in the predetermined time interval. By taking the first time-step as a reference 
point, the average atomic position is calculated throughout whole the trajectory. 
2.1.1.2 Root Mean Square Fluctuation (RMSF) 
Root mean square fluctuation (RMSF) gives the information about the local 
flexibility of the protein. RMSF is defined as:  
 
𝑅𝑀𝑆𝐹௜ = ට
ଵ
்
∑ (⟨𝑟௜(𝑡) − 𝑟పഥ⟩)ଶ்௧     (2) 
 
where 𝑇 is the total frame number, 𝑟௜(𝑡) is the position of the ith atom in tth frame, and 
𝑟పഥ is the average position of the ith atom according to the frame. RMSF takes mean 
structure over the trajectory as a reference [36].  
2.1.1.3 Principal Component Analysis (PCA) 
Molecular Dynamics simulations can provide a considerable amount of data 
which needs to be processed. At this point, reducing produced data into smaller data 
without losing any crucial information via clustering methods is an essential step.   
Principle component analysis is a mathematical method based on the covariance 
matrix, useful for finding correlated motions by reducing the dimensionality of datasets 
[37, 38]. By diagonalizing the covariance matrix, the essential motions -principal 
components-  are extracted. 
The first step is superposing all the conformations through the trajectory. With the 
gathering of the displacement information from the first step, constructing a covariance 
matrix is the second step. For a system consists of N residues, which is the total number 
of atoms in the molecule, the covariance matrix has the size of 3Nx3N [39]: 
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                      (3)         
  
                                   
Where, C is the covariance matrix and xi and xj are the displacement of ith and jth 
atom respectively. 
Decomposition of the covariance matrix needs to be done to extract the 
information of direction and magnitude of the displacement. 
 
                                                                                                                                              (4) 
While is an orthonormal matrix whose columns are eigenvectors-also called as 
modes and is a diagonal matrix which has the eigenvalues. Eigenvectors(Q) have the 
information of the direction of the motion. While eigenvalues(λ) give the insight of the 
magnitude of the motion. In this work, we display the contribution of the slowest mode 
of motion (1st PCA) by projecting the eigenvectors on the protein structure. 
2.1.1.4 Cross-Correlation Analysis 
Cross-correlation analysis is used for identifying correlated motions of a protein 
in its equilibrated state [37]. Cross-correlation is defined as follows: 
 
𝑐௜,௝ =
ർ௱ோ೔⋅௱ோ಻̇඀
ට⟨௱ோ೔⋅௱ோ೔⟩ർ௱ோ಻̇⋅௱ோ಻̇඀
   (5) 
 
While ΔRi is the displacement vector of residue ⅈ and ΔRj represents the 
displacement vector of residue j. The cross-correlation value varies between -1, total 
anticorrelation, and 1, total correlation, and represents the level of variation between 
residues. In the representation of the cross-correlation maps, red and blue represents 
positive and negative correlation, respectively. The cross-correlation analysis is 
performed by considering only Cα atoms of the amino acids in the protein. 
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2.2 Free Energy Perturbation (FEP) Calculations 
Paramount in understanding the relationship between structure and function of a 
biological process are thermodynamic features, more specifically free energy change 
[38]. The thermodynamic features of a system may become altered due to ligand binding 
or protein side-chain mutations [39]. 
 
Figure 2.1. Thermodynamic cycle of H372A mutation. 
 
In 1954, Zwanzig revealed the relationship between the free energy of the system 
and the average of the potential energy differences [40].  
𝑒(ିఉ௱ீ) = ൻ𝑒(ିఉ௱௎)ൿ଴
௘௤
      (6) 
 
The free energy difference is calculated between reference and target systems, 
which has the coupling parameter, λ, between 0 and 1, where 0 and 1 represent the 
initial and final states, respectively [41]. The potential energy difference between two 
states are calculated via the alchemical transformation equation as follows: 
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𝑈(𝜆௜) = 𝜆௜𝑈଴ + (1 − 𝜆௜)𝑈ଵ = 𝑈଴ + 𝜆௜𝛥𝑈   (7) 
 
If there are n number of intermediate states, windows, between the reference and 
target system, the partition function equals as follows: 
 
𝛥𝐺 = − ଵ
ఉ
𝑙𝑛 ቀொభ
ொమ
ቁ = − ଵ
ఉ
𝑙𝑛 ቀொಾ
ொబ
ொభ
ொಾ
ቁ = 𝛥𝐴଴,ெ + 𝛥𝐴ெ,ଵ   (8) 
 
Here 𝛥𝐺଴,ெ and 𝛥𝐺ெ,ଵ represent the free energy differences between 0 and M, and 
M and 1 intermediate states [42]. N number of windows allows calculating 𝛥𝛥𝐺.  
While calculating free energy changes, the system space is sampled in both ways, 
forward and backward. The ratio of the probability distribution equals the difference 
between free energy and potential energy. To increase the overlap of a probability 
distribution, sampling carries great significance [42]. Thereby, the window number is set 
as 32 between WT and mutated states in our simulations (Fig. 2.2). Each window is 200 
ps long with 50ps equilibration and 150 ps data generation.  
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Figure 2.2. Intermediate steps between the initial and final steps. Windows for 
H372A(A), intermediate states in the case of G330T(B). For intermediate steps, red color 
represents vanishing atoms and blue color represents appearing atoms. 
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Chapter 3 
 
Structural and thermodynamic information: Free Energy Perturbation 
Calculations 
 
To determine which states of the PDZ domain would be proper for free energy 
perturbation calculations, we first carry out 200 ns MD simulations on apo, and either 
ligand bound forms of PDZ domains for the wild type, G330T, H372A, and the double 
mutant forms of the protein. The initial structures for FEP calculations are taken from the 
50ns, 100ns, 150ns and 200ns time points of the samples. To decide whether the 
simulations and sampling are reliable, free energy perturbation calculations are compared 
with an experimental study reporting Kd values which shows the binding affinity of PDZ 
domain in the presence of ligand class I and II [18]. 
 
3.1 How the RMSD differed due to mutation types and ligand-bound/unbound 
states? 
The wild-type, H372A, G330T single mutants and double mutant cases were 
simulated to understand the dynamics of the PDZ domain in the presence and absence of 
both ligand types. The simulations were carried out for 200 ns and it is observed that the 
equilibration time varies considerably among different states. 
By comparing the RMSD results, it is aimed to understand whether the behavior 
of the protein has changed between the two simulations.  For each case, ligand unbound, 
ligand class-I bound, and ligand class-II bound conditions were compared. 
 For WT in the absence of ligand, the initial simulation has an RMSD range 
between 2 and 3 Å, while the repeated simulation has a range of 3 to 4 Å. In Figure 3.1A, 
the green shaded area shows a distinct state sampled between 80-120 ns. The reason is 
that, the N terminus is only twisted on α2 (regions are as defined in Fig. 1.3B) within this 
16 
 
interval (a sample snapshot is shown in Fig. 3.1B). Outside this range, the N terminus 
moves freely. Although the molecules have different states throughout the trajectory, the 
two simulations seem to have an almost identical endpoint (Figure 3.1A). 
  
 When the results are compared to the ligand-bound and unbound conditions of 
the wild type protein, it has been observed that ligand binding increases the RMSD values 
of the protein. RMSD was increased to 3.5 and 4 Å by ligand binding, in both simulations 
(Fig. 3.1C, 3.1D). However, the movement of the N terminus is different from the case 
where the ligand is absent. In the presence of ligand class II, the N terminus is packed on 
the C terminus in the range of 130-200 ns in one simulation (Fig. 3.1E, dark blue). Apart 
from these observations on RMSD, there is no significant difference in terms of ligand 
class I and ligand class-II bound status.  
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Figure 3.1. RMSD results and sample snapshots for WT in the absence of ligand 
and in the presence of both ligand types. RMSD result in the absence of the 
ligand(A). The state of the protein in the dark green shaded interval in the previous 
figure (B). RMSD results in the presence of ligand class I (C). RMSD results in the 
presence of ligand class II (D). The conformation of the protein in the dark blue shaded 
area in the previous figure(E). L stands for the ligand class I and L* represents ligand 
class II. 
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 As it has shown in the figure 3.2, the effect of the G330T mutation on the dynamics 
of the protein differs in the absence and presence of ligand.RMSD results show that the 
protein in Ligand class-I bound state has two different states, 1-120 ns and 120-200 ns 
(Fig. 3.2B). This difference is due to N terminus as it is in the case of WT. Until 120 ns, 
the N terminus is curled over the α2 region and after 120ns the N terminus moves freely 
and is not fixed to any region of the protein (Fig. 3.2 C). In the presence of ligand class 
II, due to N terminus movements, protein has a distinct equilibrated state between 75 and 
120ns (Fig. 3.2D). In this region, N terminus is packaged into the α2 region of the protein 
(Fig. 3.2E). 
 For the G330T mutation, in the absence of ligand (Fig. 3.2A) and in the presence 
of ligand II, the average value of RMSD is between 3 and 4 Å. This result is also valid 
for repeated simulations. Taking these results into consideration, there is no significant 
difference between the RMSD averages, in the absence of ligands and their presence.  
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Figure 3.2. RMSD results and sample snapshots for G330T in the absence of ligand 
and in the presence of both ligand types. RMSD results in the absence of ligand (A). 
RMSD in the presence of ligand class I (B). The conformational state between 120-150 
ns in the dark pink shaded region ligand class-I bound state (C). Ligand class-II bound 
condition RMSDs (D). Representation of N terminus position in the dark orange shaded 
region (E). L stands for the ligand class I and L* represents ligand class II. 
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 For the H372A mutation case, in the absence of ligand, the repeated simulation has 
a slightly lower RMSD when it is compared to the first simulation, but the variation 
pattern of the protein is similar (Fig. 3.3A). In the case of ligand class-I bound case, 
RMSD results are nearly identical and have the most equilibrated condition (Fig. 3.3B). 
In terms of ligand class-II bound instance, even though the fluctuations of the RMSD is 
high, its average is between 2 and 3 Å (Fig. 3.3C).  
 
 
 
 
 
 
21 
 
 
 
Figure 3.3. RMSD results for H372A in the absence of ligand (A) and in the presence 
of ligand class-I (B) and II (C). L stands for the ligand class I and L* represents ligand 
class II. 
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 As demonstrated in the figure 3.4, the effect of the DM mutation on the dynamics of 
the protein differs in the absence and presence of ligand. For the double mutant (DM) 
cases, when there is no ligand attached to the protein, protein has shown frequent 
fluctuations during the whole trajectory, that situation is also true for the repeat simulation 
(Fig. 3.4A). When the average RMSD value is taken into consideration, it varies between 
2.7 and 3 Å. Nevertheless, at ligand class I bound state, protein equilibrated a short while 
after simulation started and was fixed at 4 Å for both replica simulations (Fig. 3.4B). 
During the whole trajectory of ligand class-I bound state, N terminus is curled towards 
α2 region (Fig. 3.4C) In the case of ligand class-II bound state, simulations have different 
states, but have a similar endpoint (Fig. 3.4D). It is observed that N terminus curled on 
itself between 70 and 90 ns in the presence of ligand class II (Fig. 3.4D). As a second 
conformation, N terminus is close to C terminus between 90 and 200 ns (Fig. 3.4E). 
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Figure 3.4. RMSD results and sample snapshots for the G330T-H372A double 
mutation in the absence of ligand and in the presence of both ligand types. RMSD 
results when ligands are absent (A). Ligand class-I presence effect on the RMSD (B). N 
terminus location in the presence of ligand class I (C). RMSD results in the presence of 
ligand class-II (D). Different conformations of the protein in ligand class-II bound state 
(E and F). L stands for the ligand class I and L* represents ligand class II. 
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3.2 Free Energy Perturbation Calculations 
According to the results of RMSD, it was decided to take samples from 50ns, 
100ns, 150ns and 200 ns for the H372A, G330T and DM cases from the first set of 
simulations (the ones shown in dark colors in Figure 3.2-3.4). To understand how reliable 
the results obtained are, the calculations were compared with the experimental results and 
were observed to be consistent. 
3.2.1 G330T and DM cases 
 By taking the average of four FEP simulations, 𝛥𝛥𝐺 values are calculated in the 
presence of ligand class I and II for G330T and DM cases. FEP calculation results are 
then compared to experimental results. 
 
 
Figure 3.5 Kd results in the presence of ligand class-I and II with G330T and DM. 
L stands for the ligand class I and L* represents ligand class II. 
 
  
The Kd values that are obtained from the binding affinity experiments [18] (Fig. 
3.7) were again calculated via eq.7 and eq.8. 
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Figure 3.6. 𝜟𝑮 and 𝜟𝜟𝑮 results obtained from FEP simulations(blue) and 
experiments(red).  Calculations are done by eq.7 and eq.8. L stands for the ligand class 
I and L* represents ligand class II. 
 
 More negative results are obtained when it is compared to H372A mutant 
conditions since class bridging mutant, G330T, allows binding of both ligand types [18]. 
Ligand class II has a more negative 𝛥𝐺 value which shows that in the presence of the 
G330T mutation, ligand class-II binding is more favorable. 
 While the experimental 𝛥𝛥𝐺 is -4.7 kcal/mol, the FEP results is -5.2 kcal/mol. 
The fact that the FEP and the experimental results from G330T the mutation case are 
similar to each other shows the sampling for FEP and MD simulations are reliable. 
 In the Figure 3.6, cycles of G330T and DM is represented in the absence and 
presence of ligand classes. a value in the absence of ligand class I cycle is 5.2 kcal/mol 
and b value in the absence of ligand class I cycle is 12.6 kcal/mol. In the ligand class II 
cycle, a is 7.2 kcal/mol and b is 10.0 kcal/mol. Due to the sum of a and b values are 
almost equal in the condition of absence of ligands cases, they cancel out each other. 
3.2.2 H372A and DM cases 
 
 By taking the average of four FEP simulations, the 𝛥𝛥𝐺 values are calculated 
in the presence of ligand class I and II for H372A and DM cases and compared with the 
experimental results (Kd are listed in Figure 3.5) [18].  
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Figure 3.7 Kd results in the presence of ligand class-I and II with H372A and DM. 
L stands for the ligand class I and L* represents ligand class II. 
  
 
From the Kd values that are obtained from the binding affinity experiments [18] 
(Fig. 3.5) we calculate the relative free energy differences using the following relations:   
 
    𝛥𝐺 = 𝑅𝑇 𝑙𝑛(𝐾ௗ)    (7) 
 
   𝛥𝛥𝐺 = 𝑅𝑇 𝑙𝑛 ൬௄೏మ
௄೏భ
൰    (8) 
  
  
 The more negative ΔG is, the better the ligand binds. The most negative results 
were calculated in cases where ligand class II was bound under H372A and DM 
conditions, indicating that ligand class-II is preferred to ligand class-I. It has also been 
shown by FEP calculations that the H372A mutation does not allow class I binding.  
 
 While 𝛥𝛥𝐺 of experimental results is -4.7 kcal/mol, FEP results is -8.1 kcal/mol. 
The fact that the FEP and the experimental results display non-contradicting trends 
suggests that the sampling for FEP simulations and MD simulations are reliable. 
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 In the Figure 3.8, cycles of H372A and DM is represented in the absence and 
presence of ligand classes. a value in the absence of ligand class I cycle is 13.0 kcal/mol 
and b value in the absence of ligand class I cycle is 4.9 kcal/mol. In the ligand class II 
cycle, a is 12.1 kcal/mol and b is 2.2 kcal/mol. Because of the close values of the sum of 
a and b in the thermodynamic cycle, they cancel out each other. 
 
 
Figure 3.8. 𝜟𝑮 results obtained from FEP simulations(blue) and experiments(red).  
Calculations are done by eq.7 and eq.8. L stands for the ligand class I and L* represents 
ligand class II. 
 
The fact that the results that are obtained from both the G330T and H372A 
mutations are close to the experimental results indicate that the examination of MD 
simulations is reasonable for determining the PDZ domain functions. 
The values a and b for the free energy cost of the mutation in ligand free protein 
may be calculated. However, we have not gone forward with this calculation as they 
cancel out while we compare the binding free energy differences. 
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Chapter 4 
 
Understanding the Effects of Mutations on the Dynamics of the Protein: Molecular 
Dynamics Simulations 
 
4.1 Results 
 
4.1.1 Entropic cost of mutations and ligand binding: RMSF Results 
 RMSF results show that there are certain regions of the protein that are affected due 
to ligand binding or mutations. Therefore, in the name of understanding the fluctuations 
completely, the cost of mutations and ligand binding are analyzed. We note that all the 
following results are averaged over 40 ns apart regions following equilibration of the both 
replica. Thus, the 80-120, 120-160 and 160-200 ns portions of the trajectories are utilized 
for each replica, resulting in a sample size of 6 sets. The displayed error bars are calculated 
accordingly. 
4.1.1.1 Cost of Mutations 
 In this subsection, we analyze the effect of adding mutations to the wild type 
protein in terms of the fluctuation patterns of the residues. 
 As demonstrated in Figure 4.1, the absence of ligand case, DM mutation increased 
the fluctuations in most of the regions. However, it loses its domination, especially on 
the N and C terminus sites. On the other hand, H372A mutation does not affect the WT 
as much as the other mutations. On the N terminal region, the H372A mutation leads to 
an appreciable decrease when it is compared to other mutations. In contrast to the N 
terminus, the C terminus results indicate that all mutations have a fluctuation-decreasing 
effect. 
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Figure 4.1. RMSF results in the absence of ligand. 
 
 Figure 4.2 represents the RMSF change regarding ligand class I presence. In terms 
of ligand class I binding, G330T has an additive effect of fluctuations on all the regions 
of the protein. Even though DM and H372A mutation inhibit the class-I type ligand 
binding, there is no significant difference from the WT in terms of residue fluctuations 
which bindins to the class-I ligand. Especially on the N terminus site, where the WT has 
been taken as a reference point, it can be concluded that G330T mutation results in an 
increase, but H372A and DM cause a decrease. Corresponding outcomes of H372A and 
DM mutation effects on the dynamics suggest that in the presence of class I ligand, 
H372A mutation is much more effective than the G330T mutation (Fig. 4.2). 
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Figure 4.2. RMSF results in the presence of ligand class I. 
 
  As it has shown in Figure 4.3, ligand class II can bind to all mutation types except 
WT, but this did not cause a significant difference in RMSF results. WT has shown only 
a slight increase, but there are no significant differences. On the N terminus site, only the 
DM case has a decreasing effect on the fluctuations (Fig. 4.3).   
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Figure 4.3. RMSF results in the presence of ligand class II. 
4.1.1.2 Cost of ligand preference and ligand binding 
 In this subsection, we repolt the data of the previous one, but by grouping them in 
terms of the changes caused by ligand binding. 
For WT, it is known that class I is preferable, but it does not bind to class II type 
ligand. As shown in figure 4.4, apart from the C terminus, the presence of ligand class II 
increases the fluctuations of the protein in all residues, but it is not a dramatic difference. 
On the C terminus site, the presence of both ligand reduce the fluctuation dramatically. It 
can be deduced that ligand presence decreases the variation and the presence of ligand 
class II slightly raises the fluctuations as a whole. Conversely,  ligand class I binding does 
not cause any noticeable effect compared to the lack of ligand (Fig 4.4). 
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Figure 4.4. RMSF results for WT case. 
G330T mutation allows to bind both classes of ligands, the only difference is their 
binding affinities. Regarding figure 4.5, If the absence of a ligand case is taken as a 
reference, ligand class I presence results in an insignificant rise. On the contrary, ligand 
class II binding, decreases the fluctuation in all residues, albeit in a minimal amount (Fig 
4.5). 
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Figure 4.5. RMSF results for the G330T case. 
H372A mutation inhibits the ligand class I binding, and only allows class II type 
ligand binding. However, as it has shown in the Figure 4.6, besides the N terminus, 
there is no consequential variance between the absence and the presence of the ligand. 
The presence of Ligand class I pacifies the N terminus when it is compared with the 
absence of ligand and presence of ligand class-II cases. 
 
Figure 4.6. RMSF results for H372A case. 
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DM approves only ligand class-II binding. However, as the results have shown in 
Figure 4.7, that there is an equivalent effect of both classes I and II type ligand presence 
on the fluctuation patterns. Apparently, the presence of a ligand decreases the fluctuation 
of overall protein, especially at the N terminus. It can be concluded that, for the DM case, 
ligand presence ease the fluctuation for all residues, in contrast to ligand absence (Fig. 
4.7). 
 
 
 
Figure 4.7. RMSF results for DM case. 
4.1.2 Deeper Understanding of Fluctuations: Cross-Correlation and PCA Results 
4.1.2.1 Absence of Ligand 
To have the better understanding of mutations on the dynamics of the protein, WT 
is taken as a reference structure. G330T mutation increases both negative and positive 
correlation for the whole protein. H372A mutation is more similar to WT, but between 
residues 330-350 this mutation decreases the positive correlations. DM has equivalent 
results with the G330T mutant condition. When all results are taken into consideration, 
in the absence of a ligand G330T is more effective than H372A when they are present 
together as DM (Fig 4.8). 
35 
 
 
 
Figure 4.8. Cross-correlation maps in the absence of ligand. (For Cross-correlation 
matrix calculations, first 80 ns parts of the simulations are excluded. Calculations belong 
only to the first set of simulations.) 
 
4.1.2.2 Presence of Ligand Class I 
In the presence of ligand class-I, only the G330T mutation intensifies both positive 
and negative correlations. Both H372A mutation and DM increases the negative 
correlation in N terminus region and slightly increases the positive correlation, but both 
have comparable results with the WT condition. The resemblance in H372A and DM 
maps suggest that H372A mutation is more impressive than G330T mutation in the 
presence of a ligand which explains the inhibitory effect of H372A mutation towards the 
ligand class I binding (Fig. 4.9). 
 
 
Figure 4.9. Cross-correlation maps in the presence of ligand class-I. (For Cross-
correlation matrix calculations, first 80 ns parts of the simulations are excluded. 
Calculations belong only to the first set of simulations.) 
 
The effectiveness of the H372A mutation in the presence of ligand class I is also 
observed via PCA results. We first note that the major mode of motion is always on the 
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N-terminus region. It is observed that H372A mutation introduces more fluctuation in the 
binding pocket which leads a distortion in the binding pocket and prevents the ligand 
binding (Fig. 4.10C). Because the H372A mutant is more effective than G330T mutant 
in the presence of ligand class I, binding inhibition is also effective in the DM condition 
(Fig. 4.10D). On the other hand, like the WT case, the binding pocket is stable in the 
condition of G330T mutant, so that ligand class I can bind to the protein (Fig. 4.10B).  
 
 
Figure 4.10. PCA results in the presence of ligand class-I. (For PCA calculations, 
first 80 ns parts of the simulations are excluded. Only first modes are considered) 
4.1.2.3 Presence of Ligand Class II 
 In ligand class II circumstance, G330T mutation increased both negative and 
positive correlation in the whole protein. Although not as much as the G330T mutation, 
the H372A mutation also increased positive and negative correlations. On the other hand, 
the DM condition shows the effects of both G330T and H372A mutation at the same time 
(Fig. 4.11).   
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Figure 4.11. Cross-correlation maps in the presence of ligand class-II. (For Cross-
correlation matrix calculations, first 80 ns parts of the simulations are excluded. 
Calculations belong only to the first set of simulations.) 
 
 The effects of mutants on the dynamics of the protein are observed in the 1st 
PCA. In the presence of ligand class-II, an intensive fluctuation on the binding site, 
especially at GLGF motif site, is observed for the WT condition (Fig. 4.12A). However, 
the disturbing fluctuation at the GLGF motif region is eased down with H372A and 
G330T mutation. Therefore, G330T, H372A and DM mutants all allow ligand class-II 
binding (Fig. 4.12B, C, D). 
 
 
Figure 4.12. PCA results in the presence of ligand class-II. (For PCA calculations, first 
80 ns parts of the simulations are excluded. Only first modes are considered) 
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4.1.3 How stable are the ligands during the simulation? Hydrogen Bond 
Occupancies  
  
 It has observed that, under different mutation presences the dynamics of the 
protein altered. Therefore, we also wanted to see the effect of the mutations on the 
stability of ligands.  
Hydrogen bonds between the ligand and the bonding pocket were observed for 200 ns 
and the hydrogen bond occupancies were calculated as a percentage, with the length of 
the hydrogen bond being limited to a maximum of 3 Å. 
 Hydrogen bond occupations have changed over mutation and ligand type. In the 
presence of ligand class I, occupations of residues 327, 329 and 339 appear to be 
strengthened (Figure 4.13 B, C, D). However, occupations of hydrogen bonds of 323, 325 
and 326 residues were significantly reduced compared to WT (Fig. 4.13 B, C, D). Given 
that only the WT and G330T mutants can bind ligand class I and their hydrogen bond 
occupancy results are equivalent, it is important to note that not only the amount of 
increase but also the residues in which the increase occurs matters. 
 
 
Figure 4.13. Hydrogen bond occupancy results under mutations and ligand class-I 
presence. H-bond occupancies for WT (A). In the presence of G330T mutation with 
ligand class I (B). H372A mutation effect on the hydrogen bond occupancies (C). The 
effect of double mutation on the occupancies (D). The representation of the interactions 
between binding pocket and ligand class I (E).  
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 In the case of ligand class-II, it is known that it does not bind to WT, but all 
introduced mutations allow the binding to this ligand [18]. From FEP calculations and 
ligand affinity assay results, it is known that the DM binds better to the class-II ligand. 
Hydrogen bond occupancy results also indicate that ligand class-II binds better to DM 
than others (Figure 4.14D). The hydrogen bond in WT shows weaker bonds at residue 
329 when compared to other conditions (Figure 4.14A). This may indicate the importance 
of the location of hydrogen bonds. 
 
 
Figure 4.14. Hydrogen bond occupancy results under mutations and ligand class-II 
presence. H-bond occupancies for WT (A). In the presence of G330T mutation with 
ligand class II (B). H372A mutation effect on the hydrogen bond occupancies (C). The 
effect of double mutation on the occupancies (D). The representation of the interactions 
between binding pocket and ligand class II (E). 
 
 
 
 
 
40 
 
 
 
Chapter 5 
 
A Simple Model to Explain Entropy-Enthalpy Compensation in PDZ Domain 
 
 PDZ domains are small proteins that are widely used for understanding the 
single domain allostery. Following the discovery that conformational change is not 
always necessary for allostery to occur [21][25], and with the first study of the allosteric 
pathways of the PDZ domain in 1999 [29], it became the favored model protein to 
understand single domain allostery. 
 Mutation may be thought of as a local perturbation, which may lead to a change 
in the ligand preference due to the alterations in the active site [28]. In this study, the third 
PDZ domain of the PSD-95 is used as a model molecule. Third PDZ domain has two 
possible ligand choices whose preferences may be modulated by perturbing two 
important residues, H372 and G330. It is observed that the H372A mutation, which is in 
the binding pocket and has a direct effect on the ligand binding, has an inhibitory effect 
on ligand class I [18] (Fig. 1.4). Therefore, it is known to be a ‘class changing’ mutation. 
On the other hand, G330T mutation allows the protein to bind both ligand class-I and II. 
Even though G330 is not located in the binding pocket, due to the indirect but significant 
effect of the mutation on this residue, it is considered as an ‘allosteric effect’[18] (Fig. 
1.4). Because G330T mutant allows binding both classes, it is called a ‘class bridging’ 
mutation[18]. 
 FEP simulations and experimental results [18] show the relationship between 
mutations and ligand binding affinities (Fig. 3.6, 3.8). As it is excepted, H372A and DM 
allow the binding of ligand class-II but not ligand class-I. In addition, PDZ domains which 
have G330T mutant can bind both ligand classes. 
 MD analysis showed the dynamic effects of the mutations. The new movements 
that are introduced in the binding pocket, especially at the region of GLGF motif, due to 
H372A and G330T mutation are the determinants of binding. Both PCA and cross-
correlation results are compatible with ligand binding affinity results. 
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 We find that the binding affinities are intimately related to entropy enthalpy 
compensation. Recalling 𝛥𝐺 = 𝛥𝐻 − 𝑇𝛥𝑆, we first crudely associate 𝛥𝐻 of binding by 
the forming and disappearing H bonds between ligand and protein in the binding pocket 
(Section 4.1.3) as these bonds are expected to make the largest change in the energetic 
contributions. On the other hand, the fluctuations may be translated into conformational 
entropy change through the sum of the eigenvalues of the matrices visualized in figures 
4.9 and 4.10 for L and L* bound cases, respectively. 𝛥𝐺 has already been calculated, both 
experimentally and computationally (Section 3.2). These are summarized in Table 5.1. 
 
Table 5.1. 𝚫𝐇, 𝚫𝐒, 𝚫𝐆 values from FEP calculations and MD trajectory analysis. 
 Kd (M) 𝚫𝐆 (kcal/mol) Enthalpic 
contributionsa  
Entropic 
contributionsb 
WT(L) 0.8 -8.6 ± 0.1 48% 83 
WT(L*) 36 -6.3 ± 0.1 65% 111 
G330T(L) 2.2 -7.9 ± 0.2 85% 379 
G330T(L*) 1.8 -8.1 ± 0.2 76% 491 
H372A(L) 26.9 -6.5 ± 0.2 62% 97 
H372A(L*) 1.9 -8.1 ± 0.2 73% 186 
DM(L) 22.1 -6.6 ± 0.1 74% 95 
DM(L*) 0.5 -8.9 ± 0.1 80% 188 
a) quantified by hydrogen bond occupancies 
b) quantified by sum of the eigenvalues of correlation matrices 
 
As it is mentioned in discussing the free energy perturbation calculations, the more 
negative ΔG, the better the ligand binds. For the H372A mutation, L* binding is 
significantly better than L. In fact, this is directly associated with the increase in the 
number of hydrogen bond occurrences in the binding pocket (negative enthalpic 
contribution) and the increase in the sum of the eigenvalues (positive entropic 
contribution). The same is true for the DM. On the other hand, the case of the G330T 
mutation which allows both ligands to bind is subtler. While the change in the hydrogen 
bonding occupancies with respect to the WT is larger for the class I ligand than that of 
class II ligand, the conformational entropy change for the latter is dominant. Thus, the 
G330T mutant prefers to bind L due mainly to enthalpic gain, it bind L* due to the 
42 
 
entropic gain. We note that the N terminus has a great contribution in the allosteric 
modulation of ligand binding in the PDZ domains. Thus, rather than a pathway view that 
analyses the changes between the effector and binding sites in allosteric models, we 
suggest that the ensemble view of allostery provides a better description of site-to-site 
coupling [43].  
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